John Newman
Stock Analyst at Canaccord Genuity
(3.58)
# 2,103
Out of 4,405 analysts
935
Total ratings
42.4%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by John Newman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintained: Buy | $30 → $42 | $29.82 | +40.85% | 6 | Jun 11, 2026 | |
| NUVL Nuvalent | Downgraded: Hold | $126 | $123.45 | +2.07% | 14 | Jun 10, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Maintained: Buy | $23 | $7.46 | +208.31% | 2 | Jun 8, 2026 | |
| BNTX BioNTech SE | Maintained: Buy | $158 | $89.54 | +76.46% | 23 | Jun 1, 2026 | |
| TYRA Tyra Biosciences | Maintained: Buy | $50 | $25.57 | +95.54% | 5 | Jun 1, 2026 | |
| CMPX Compass Therapeutics | Maintained: Buy | $7 | $2.01 | +248.26% | 12 | May 22, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $1,057 → $875 | $611.48 | +43.10% | 117 | May 19, 2026 | |
| MRKR Marker Therapeutics | Maintained: Buy | $8 | $1.37 | +483.94% | 12 | May 19, 2026 | |
| CADL Candel Therapeutics | Maintained: Buy | $25 | $8.16 | +206.37% | 12 | May 18, 2026 | |
| ACET Adicet Bio | Maintained: Buy | $18 | $7.55 | +138.41% | 26 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.88 | +644.68% | 37 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.28 | +603.13% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $10.46 | +24.28% | 90 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $11.77 | +78.50% | 26 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $12.09 | +214.31% | 11 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $6.27 | +250.88% | 67 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.82 | n/a | 19 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.91 | n/a | 18 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $300 | $13.68 | n/a | 34 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $8.06 | n/a | 45 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $627.59 → $251.04 | $2.19 | n/a | 40 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $44 | $28.77 | n/a | 57 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $3 | $0.0057 | n/a | 24 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $352.54 | $17.05 | n/a | 2 | May 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 | $14.80 | n/a | 1 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $10.68 | n/a | 25 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.9256 | n/a | 12 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13.95 | $9.32 | n/a | 1 | Mar 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $1.71 | n/a | 18 | Jun 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $6 | $2.01 | n/a | 18 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $5 | $52.19 | n/a | 17 | Jun 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $15.85 | n/a | 10 | Mar 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $18.34 | n/a | 11 | Mar 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $13.07 | n/a | 12 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $60 | $2.03 | n/a | 13 | Nov 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $15 | $2.20 | n/a | 4 | Oct 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $12.97 | n/a | 17 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $5.27 | n/a | 9 | Jul 26, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $90 | $28.62 | n/a | 1 | Jun 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $2.66 | n/a | 1 | May 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $33.05 | n/a | 1 | May 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $995.87 | n/a | 1 | Mar 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $6 | $0.82 | n/a | 5 | Mar 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $201 | $236.17 | n/a | 5 | Mar 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $0.6226 | n/a | 1 | Jan 7, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $9 | $6.97 | n/a | 3 | Oct 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $127 | $199.96 | n/a | 45 | Dec 20, 2011 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 | $3.75 | n/a | 2 | Mar 15, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $81.62 | n/a | 1 | Jun 10, 2009 |
Tango Therapeutics
Jun 11, 2026
Maintained: Buy
Price Target: $30 → $42
Current: $29.82
Upside: +40.85%
Nuvalent
Jun 10, 2026
Downgraded: Hold
Price Target: $126
Current: $123.45
Upside: +2.07%
BridgeBio Oncology Therapeutics
Jun 8, 2026
Maintained: Buy
Price Target: $23
Current: $7.46
Upside: +208.31%
BioNTech SE
Jun 1, 2026
Maintained: Buy
Price Target: $158
Current: $89.54
Upside: +76.46%
Tyra Biosciences
Jun 1, 2026
Maintained: Buy
Price Target: $50
Current: $25.57
Upside: +95.54%
Compass Therapeutics
May 22, 2026
Maintained: Buy
Price Target: $7
Current: $2.01
Upside: +248.26%
Regeneron Pharmaceuticals
May 19, 2026
Maintained: Buy
Price Target: $1,057 → $875
Current: $611.48
Upside: +43.10%
Marker Therapeutics
May 19, 2026
Maintained: Buy
Price Target: $8
Current: $1.37
Upside: +483.94%
Candel Therapeutics
May 18, 2026
Maintained: Buy
Price Target: $25
Current: $8.16
Upside: +206.37%
Adicet Bio
May 14, 2026
Maintained: Buy
Price Target: $18
Current: $7.55
Upside: +138.41%
May 14, 2026
Maintained: Buy
Price Target: $14
Current: $1.88
Upside: +644.68%
May 13, 2026
Maintained: Buy
Price Target: $9
Current: $1.28
Upside: +603.13%
May 13, 2026
Maintained: Buy
Price Target: $13
Current: $10.46
Upside: +24.28%
May 8, 2026
Maintained: Buy
Price Target: $21
Current: $11.77
Upside: +78.50%
May 6, 2026
Maintained: Buy
Price Target: $38
Current: $12.09
Upside: +214.31%
May 6, 2026
Maintained: Buy
Price Target: $22
Current: $6.27
Upside: +250.88%
Nov 12, 2024
Maintained: Buy
Price Target: $5
Current: $0.82
Upside: n/a
Nov 12, 2024
Maintained: Buy
Price Target: $10
Current: $3.91
Upside: n/a
Oct 1, 2024
Maintained: Buy
Price Target: $6 → $300
Current: $13.68
Upside: n/a
Aug 8, 2024
Maintained: Buy
Price Target: $43
Current: $8.06
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $627.59 → $251.04
Current: $2.19
Upside: n/a
Feb 16, 2022
Maintained: Buy
Price Target: $52 → $44
Current: $28.77
Upside: n/a
Aug 17, 2021
Maintained: Buy
Price Target: $7 → $3
Current: $0.0057
Upside: n/a
May 26, 2021
Maintained: Buy
Price Target: $352.54
Current: $17.05
Upside: n/a
May 12, 2021
Maintained: Buy
Price Target: $31
Current: $14.80
Upside: n/a
May 3, 2021
Maintained: Buy
Price Target: $45
Current: $10.68
Upside: n/a
Mar 25, 2021
Maintained: Buy
Price Target: $5
Current: $0.9256
Upside: n/a
Mar 9, 2020
Maintained: Buy
Price Target: $13.95
Current: $9.32
Upside: n/a
Jun 26, 2019
Reiterated: Buy
Price Target: $20
Current: $1.71
Upside: n/a
Aug 13, 2018
Maintained: Buy
Price Target: $31 → $6
Current: $2.01
Upside: n/a
Jun 27, 2017
Reiterated: Buy
Price Target: $8 → $5
Current: $52.19
Upside: n/a
Mar 10, 2017
Reiterated: Buy
Price Target: $10
Current: $15.85
Upside: n/a
Mar 1, 2017
Reiterated: Buy
Price Target: $12
Current: $18.34
Upside: n/a
Dec 30, 2016
Reiterated: Buy
Price Target: $10
Current: $13.07
Upside: n/a
Nov 9, 2016
Reiterated: Buy
Price Target: $6 → $60
Current: $2.03
Upside: n/a
Oct 11, 2016
Reiterated: Buy
Price Target: $6 → $15
Current: $2.20
Upside: n/a
Aug 10, 2016
Reiterated: Buy
Price Target: $34
Current: $12.97
Upside: n/a
Jul 26, 2016
Reiterated: Buy
Price Target: $3
Current: $5.27
Upside: n/a
Jun 13, 2016
Reiterated: Hold
Price Target: $90
Current: $28.62
Upside: n/a
May 13, 2016
Reiterated: Buy
Price Target: $30
Current: $2.66
Upside: n/a
May 2, 2016
Reiterated: Buy
Price Target: $26
Current: $33.05
Upside: n/a
Mar 31, 2016
Maintained: Buy
Price Target: $18
Current: $995.87
Upside: n/a
Mar 9, 2015
Maintained: Hold
Price Target: $8 → $6
Current: $0.82
Upside: n/a
Mar 3, 2015
Reiterated: Buy
Price Target: $201
Current: $236.17
Upside: n/a
Jan 7, 2015
Initiated Coverage: Buy
Price Target: $24
Current: $0.6226
Upside: n/a
Oct 7, 2014
Downgraded: Hold
Price Target: $40 → $9
Current: $6.97
Upside: n/a
Dec 20, 2011
Rated: Buy
Price Target: $127
Current: $199.96
Upside: n/a
Mar 15, 2010
Downgraded: Sell
Price Target: $5
Current: $3.75
Upside: n/a
Jun 10, 2009
Maintained: Sell
Price Target: n/a
Current: $81.62
Upside: n/a